BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9527111)

  • 1. Expression of annexin II in human middle ear cholesteatoma.
    Kim TT; Chen CT; Huang CC
    Otolaryngol Head Neck Surg; 1998 Mar; 118(3 Pt 1):324-8. PubMed ID: 9527111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of ErbB-2 protein in human middle ear cholesteatomas.
    Sakamoto T; Kondo K; Yamasoba T; Suzuki M; Sugasawa M; Kaga K
    Laryngoscope; 2004 Nov; 114(11):1988-91. PubMed ID: 15510028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of a releasable form of annexin II by human keratinocytes.
    Karimi-Busheri F; Marcoux Y; Tredget EE; Li L; Zheng J; Ghoreishi M; Weinfeld M; Ghahary A
    J Cell Biochem; 2002; 86(4):737-47. PubMed ID: 12210740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expressions of c-jun and p53 proteins in human middle ear cholesteatoma: relationship to keratinocyte proliferation, differentiation, and programmed cell death.
    Shinoda H; Huang CC
    Laryngoscope; 1995 Nov; 105(11):1232-7. PubMed ID: 7475882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of proliferating keratinocytes in middle ear cholesteatoma using the monoclonal antibody Ki-67.
    Bujia J; Holly A; Sudhoff H; Antoli-Candela F; Tapia MG; Kastenbauer E
    ORL J Otorhinolaryngol Relat Spec; 1996; 58(1):23-6. PubMed ID: 8718533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical demonstration of c-myc oncogene product in middle ear cholesteatoma.
    Holly A; Sittinger M; Bujia J
    Eur Arch Otorhinolaryngol; 1995; 252(6):366-9. PubMed ID: 8679157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the gap junction proteins connexin 26 and connexin 43 in human middle ear cholesteatoma.
    Choung YH; Park K; Kang SO; Markov Raynov A; Ho Kim C; Choung PH
    Acta Otolaryngol; 2006 Feb; 126(2):138-43. PubMed ID: 16428189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HB-EGF expression as a potential biomarker of acquired middle ear cholesteatoma.
    Xie S; Wang X; Ren H; Liu X; Ren J; Liu W
    Acta Otolaryngol; 2017 Aug; 137(8):797-802. PubMed ID: 28498080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat shock proteins in middle ear cholesteatoma.
    Shinoda H; Huang CC
    Otolaryngol Head Neck Surg; 1996 Jan; 114(1):77-83. PubMed ID: 8570255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediation of signal transduction in keratinocytes of human middle ear cholesteatoma by ras protein.
    Huang CC; Chen CT; Huang TS; Shinoda H
    Eur Arch Otorhinolaryngol; 1996; 253(7):385-9. PubMed ID: 8891480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of epidermal differentiation in middle ear cholesteatoma.
    Stammberger M; Bujía J; Kastenbauer E
    Am J Otol; 1995 Jul; 16(4):527-31. PubMed ID: 8588655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative analysis of the proliferative capacity of cholesteatomas].
    Bernal Sprekelsen M; Ebmeyer J; Buchbinder A; Sudhoff H
    Acta Otorrinolaringol Esp; 2000 May; 51(4):299-307. PubMed ID: 10984952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of p63 and survivin in cholesteatomas.
    Park HR; Min SK; Min K; Jun SY; Seo J; Kim HJ
    Acta Otolaryngol; 2009 Mar; 129(3):268-72. PubMed ID: 18615329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression patterns of cytokeratins in cholesteatomas: evidence of increased migration and proliferation.
    Kim HJ; Tinling SP; Chole RA
    J Korean Med Sci; 2002 Jun; 17(3):381-8. PubMed ID: 12068144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleoplasm staining patterns and cell cycle-associated expression of Ki-67 in middle ear cholesteatoma.
    Raynov AM; Moon SK; Choung YH; Hong SP; Park K
    Am J Otolaryngol; 2005; 26(5):296-301. PubMed ID: 16137526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of epidermal growth factor receptor in human middle ear cholesteatoma.
    Hsu YC; Ho KY; Chai CY; Lee KW; Wang LF; Wu SC; Kuo WR; Tsai SM
    Kaohsiung J Med Sci; 2003 Oct; 19(10):497-502. PubMed ID: 14620675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of cytokines and cell cycle regulating substances in proliferation of cholesteatoma epithelium.
    Tanaka Y; Kojima H; Miyazaki H; Koga T; Moriyama H
    Laryngoscope; 1999 Jul; 109(7 Pt 1):1102-7. PubMed ID: 10401849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of intercellular adhesion molecule-1 in middle ear cholesteatoma.
    Shinoda H; Huang CC
    Eur Arch Otorhinolaryngol; 1995; 252(7):385-90. PubMed ID: 8562031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keratinocyte differentiation in acquired cholesteatoma and perforated tympanic membranes.
    Vennix PP; Kuijpers W; Peters TA; Tonnaer EL; Ramaekers FC
    Arch Otolaryngol Head Neck Surg; 1996 Aug; 122(8):825-32. PubMed ID: 8703383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of human intercellular adhesion molecules in middle ear cholesteatoma.
    Bujía J; Holly A; Kim C; Scanady N; Kastenbauer E
    Am J Otolaryngol; 1994; 15(4):271-5. PubMed ID: 7526720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.